Abstract
INTRODUCTION: Inhaled nitric oxide (iNO2) is an effective pulmonary vasodilator in treatment of pulmonary hypertension. Prior studies demonstrated a decrease in pulmonary arterial pressure and pulmonary vascular resistance and increase in cardiac output at a dosage between 20-80ppm. However, the effect of lower dosage in conjunction with high flow oxygen has not been well-studied.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
